News 2017-03-17
Porton Completes Move to New Headquarters.
Mar 17, 2017, Chongqing, China: Porton Fine Chemicals is pleased to announce the relocation of its global headquarters and Chongqing Process R&D Center to a state of the art facility located in Shuitu High-Tech Park near Chongqing International Airport, China. Located on a beautiful 20 km2 campus, Porton’s Shuitu Headquarters offers 4,800 m2 of state of the art office and conference space, and hosts all centralized corporate and back-office functions to seamlessly support our sites in China, Europe and the United States.
Porton’s Shuitu campus also features our new state of the art Chongqing Process R&D Center. Featuring 4,800 m2 of R&D space including process laboratories, analytical chemistry zone, kilo-laboratory assets, hydrogenation and process safety laboratories, our Shuitu Process R&D Center brings the collective expertise and experience of >100 process chemists and analytical scientists. We are truly excited about applying this world-class facility’s capabilities to deliver compelling, cross life-cycle chemical process innovation solutions to our valued global pharmaceutical industry customers. Contact us today to attend our Open House on June 25th, 2017 or to schedule a private tour at your convenience.
Others
MoreNews 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.